Perbedaan Esa Medika Mandiri Tbk. dan Phapros Tbk.: Esa Medika Mandiri Tbk. diperdagangkan di Rp358 (kapitalisasi pasar 620,46 M, volume 24 jam 8,41 jt), sedangkan Phapros Tbk. diperdagangkan di Rp264 (kapitalisasi pasar 221,76 M, volume 24 jam 131,5 rb). Perbedaan utamanya: Esa Medika Mandiri Tbk. jauh lebih besar — sekitar 2,8× kapitalisasi pasar Phapros Tbk., dan Esa Medika Mandiri Tbk. lebih aktif diperdagangkan (8,41 jt vs 131,5 rb). Mana yang lebih baik tergantung tujuan investasimu.
| EMMI | PEHA | |
|---|---|---|
Kapitalisasi Pasar | 620,46 M | 221,76 M |
Volume | 8,41 jt | 131,5 rb |
Lot | 84,09 rb | 1,32 rb |
Perputaran | 2,92 M | 35,27 jt |
Harga Rata-rata | 347,69 | 268,19 |
Nilai Transaksi | 2,92 M | 35,27 jt |
Harga Ekuilibrium Indikatif | 358 | 264 |
Volume Ekuilibrium Indikatif | 3,01 rb | 20 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Esa Medika Mandiri Tbk (the Company) was established in the Republic of Indonesia based on Notarial Deed No. 1 of Tuti Setiahati K Soetoro SH dated January, 26 2000. The Company commenced commercial operations in 2000.
Selengkapnya di halaman EMMI →PT Phapros Tbk was established under the name of N.V. Pharmaceutical Processing Industries, in short N.V. Phapros, based on Notarial Deed No 54 of Tan A Sioe dated 21 June 1954, which later became PT Pharmaceutical Processing Industries, in short PT Phapros based on Notarial Deed No.43 of E. Pondaag, replacing R.M. Soerojo, dated 5 September 1995, which finally became PT Phapros based on Notarial Deed No. 48 of Prof. Dr. Liliana Tedjosaputro, S.H., M.H., MM., dated 12 April 2006. The Company’s immediate and ultimate parent entity is PT Rajawali Nusantara Indonesia, incorporatedand domiciled in Indonesia.
Selengkapnya di halaman PEHA →